Cargando…
Neoadjuvant chemotherapy followed by minimally invasive esophagectomy versus primary surgery for management of esophageal carcinoma: a retrospective study
There is no consensus about the combined therapeutic strategy for esophageal squamous cell carcinoma in China. The quality control and standardization of surgery procedures were far from satisfactory in past neoadjuvant chemotherapy trials, which may underestimate the survival benefits. Therefore, w...
Autores principales: | Zheng, Yan, Li, Yin, Liu, Xianben, Zhang, Ruixiang, Wang, Zongfei, Sun, Haibo, Liu, Shilei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400690/ https://www.ncbi.nlm.nih.gov/pubmed/30854116 http://dx.doi.org/10.7150/jca.29353 |
Ejemplares similares
-
The safety of neoadjuvant chemotherapy combined with non-tube nofasting fast-track surgery for esophageal carcinoma
por: Zheng, Yan, et al.
Publicado: (2022) -
Analysis of the associated factors for severe weight loss after minimally invasive McKeown esophagectomy
por: Wang, Peiyu, et al.
Publicado: (2018) -
Reevaluation of Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma: A Meta-Analysis of Randomized Controlled Trials Over the Past 20 Years
por: Zheng, Yan, et al.
Publicado: (2015) -
Feasibility of a single mediastinal drain through the abdominal wall after esophagectomy
por: Zheng, Yan, et al.
Publicado: (2018) -
Neoadjuvant Chemotherapy Compared with Surgery for Oesophageal Carcinoma: A Retrospective Study and Missing Evidence
por: Zheng, Yan, et al.
Publicado: (2023)